Literature DB >> 31881208

Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB.

Heng-Keat Tam1, Viveka N Malviya1, Wuen-Ee Foong1, Andrea Herrmann1, Giuliano Malloci2, Paolo Ruggerone2, Attilio V Vargiu3, Klaas M Pos4.   

Abstract

AcrAB(Z)-TolC is the main drug efflux transporter complex in Escherichia coli. The extrusion of various toxic compounds depends on several drug binding sites within the trimeric AcrB transporter. Membrane-localized carboxylated substrates, such as fusidic acid and hydrophobic β-lactams, access the pump via a groove between the transmembrane helices TM1 and TM2. In this article, the transport route from the initial TM1/TM2 groove binding site toward the deep binding pocket located in the periplasmic part has been addressed via molecular modeling studies followed by functional and structural characterization of several AcrB variants. We propose that membrane-embedded drugs bind initially to the TM1/TM2 groove, are oriented by the AcrB PN2 subdomain, and are subsequently transported via a PN2/PC1 interface pathway directly toward the deep binding pocket. Our work emphasizes the exploitation of multiple transport pathways by AcrB tuned to substrate physicochemical properties related to the polyspecificity of the pump.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  crystallography; drug transport; efflux; membrane protein; molecular modeling

Mesh:

Substances:

Year:  2019        PMID: 31881208      PMCID: PMC7071731          DOI: 10.1016/j.jmb.2019.12.025

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

2.  Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Phys Chem Chem Phys       Date:  2022-07-13       Impact factor: 3.945

3.  The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux.

Authors:  Valentin V Rybenkov; Helen I Zgurskaya; Chhandosee Ganguly; Inga V Leus; Zhen Zhang; Mohammad Moniruzzaman
Journal:  Chem Rev       Date:  2021-02-17       Impact factor: 60.622

Review 4.  Structural Insights into Transporter-Mediated Drug Resistance in Infectious Diseases.

Authors:  Jonathan Kim; Rosemary J Cater; Brendon C Choy; Filippo Mancia
Journal:  J Mol Biol       Date:  2021-04-20       Impact factor: 6.151

Review 5.  Bacterial efflux transporters' polyspecificity - a gift and a curse?

Authors:  Helen I Zgurskaya; Giuliano Malloci; Brinda Chandar; Attilio V Vargiu; Paolo Ruggerone
Journal:  Curr Opin Microbiol       Date:  2021-04-30       Impact factor: 7.584

6.  New Functional Criterion for Evaluation of Homologous MDR Pumps.

Authors:  Pavel A Nazarov; Alexandra I Sorochkina; Marina V Karakozova
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

7.  Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin-Tazobactam and Ceftolozane-Tazobactam in Tigecycline-Non-Susceptible Klebsiella pneumoniae.

Authors:  Junjie Li; Qingqing Xu; Sean Ogurek; Ziqiang Li; Peiyun Wang; Qing Xie; Zike Sheng; Minggui Wang
Journal:  Infect Drug Resist       Date:  2020-11-26       Impact factor: 4.003

8.  Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.

Authors:  Coline Plé; Heng-Keat Tam; Anais Vieira Da Cruz; Nina Compagne; Juan-Carlos Jiménez-Castellanos; Reinke T Müller; Elizabeth Pradel; Wuen Ee Foong; Giuliano Malloci; Alexia Ballée; Moritz A Kirchner; Parisa Moshfegh; Adrien Herledan; Andrea Herrmann; Benoit Deprez; Nicolas Willand; Attilio Vittorio Vargiu; Klaas M Pos; Marion Flipo; Ruben C Hartkoorn
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

9.  MexAB-OprM Efflux Pump Interaction with the Peptidoglycan of Escherichia coli and Pseudomonas aeruginosa.

Authors:  Miao Ma; Margaux Lustig; Michèle Salem; Dominique Mengin-Lecreulx; Gilles Phan; Isabelle Broutin
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.

Authors:  Elizabeth M Grimsey; Chiara Fais; Robert L Marshall; Vito Ricci; Maria Laura Ciusa; Jack W Stone; Alasdair Ivens; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.